EDGAR Filing Documents for 0001062993-15-002138

Form 3 - Initial statement of beneficial ownership of securities:

SEC Accession No. 0001062993-15-002138

Filing Date

2015-04-23

Accepted

2015-04-23 06:17:38

Documents

Period of Report

2015-04-22

Document Format Files

Seq	Description	Document	Type	Size
1	INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	form3.html	3
1	INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	form3.xml	3	2121
2	EXHIBIT 24.1	exhibit24-1.htm	EX-24.1	4155
	Complete submission text file	0001062993-15-002138.txt		7656

Mailing Address 35 WILBUR STREET LYNBROOK NY 11563

Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000

BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AUXILIUM PHARMACEUTICALS, INC. 40 VALLEY STREAM PARKWAY MALVERN PA 19355

Business Address

Type: 3 | Act: 34 | File No.: 001-34236 | Film No.: 15786838